1. Home
  2. ELTX vs DIT Comparison

ELTX vs DIT Comparison

Compare ELTX & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

N/A

Current Price

$1.92

Market Cap

63.3M

Sector

Health Care

ML Signal

N/A

Logo AMCON Distributing Company

DIT

AMCON Distributing Company

N/A

Current Price

$67.56

Market Cap

64.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
ELTX
DIT
Founded
2011
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Food Distributors
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
63.3M
64.4M
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
ELTX
DIT
Price
$1.92
$67.56
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $13.67
N/A
AVG Volume (30 Days)
★ 324.7K
264.0
Earning Date
11-12-2026
08-05-2026
Dividend Yield
N/A
★ 0.71%
EPS Growth
★ 39.29
N/A
EPS
N/A
★ 1.40
Revenue
$2,301,000.00
★ $1,392,388,157.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$48.26
Revenue Growth
N/A
★ 5.30
52 Week Low
$1.71
$59.15
52 Week High
$16.00
$122.00

Technical Indicators

Market Signals
Indicator
ELTX
DIT
Relative Strength Index (RSI) 23.58 47.94
Support Level $1.71 $59.15
Resistance Level $3.32 $74.55
Average True Range (ATR) 0.11 0.53
MACD 0.04 0.39
Stochastic Oscillator 29.88 35.74

Price Performance

Historical Comparison
ELTX
DIT

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

Share on Social Networks: